Vinge has advised Gränges AB (publ) in connection with a fully guaranteed rights issue of approximat…
Vinge has advised Offentliga Hus i Norden AB (publ) (“Offentliga Hus”) in connection with its listin…
The board of directors of Hansa Biopharma has, on the basis of an authorisation granted from the ann…
On 7 November 2019, Vonovia SE announced, through its indirectly wholly-owned subsidiary HomeStar In…
Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung disease…
Veoneer, Inc. (“Veoneer”) has completed a USD 600 million capital raise, consisting of two concurren…
Vinge has advised Yilport Holding AS and Yilport Sweden Terminal Investments AB (“Yilport Sweden”) i…
Vinge has advised AB Max Sievert in connection with its acquisition of Nordic Traction Group AB and…
Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with its investment in Voi Techn…
Vinge has advised Autoliv, Inc. (“Autoliv”) and Veoneer, Inc. (“Veoneer”) in connection with the spi…
Vinge advises Danske Bank A/S, Danmark, Sverige Filial and Skandinaviska Enskilda Banken (publ) who…
Vinge advises Nordea Bank AB (publ) and Skandinaviska Enskilda Banken (publ) who are acting as Joint…
The board of directors of Nuevolution has resolved on a directed new issue of shares, whereby Nuevol…
